Food Chemistry 448 (2024) 139157
2
demonstrated gastric digestion of the non-bitter tasting milk protein
casein to release bitter peptides that stimulated mechanisms of gastric
acid secretion by immortalized human parietal cells (HGT-1) via func-
tional involvement of TAS2R16 and TAS2R38 (Richter et al., 2022).
Besides digestive processes, TAS2Rs have also been shown to play a role
in preventing immune competent cells from a stimulus-evoked release of
pro-inammatory cytokines (Liszt et al., 2022;Tiroch et al., 2021; Tiroch
et al., 2023). In immortalized human gingival broblasts (HGF-1 cells),
the release of the pro-inammatory interleukin 6, evoked by treatment
with lipopolysaccharides (LPS) from Porphyromonas gingivalis, was
reduced by various TAS2R agonists and TAS2R50 siRNA knock-down
(Tiroch et al., 2021; Tiroch et al., 2023).
From a mechanistic perspective, activation of TAS2R16 by its agonist
salicin (Bufe, Hofmann, Krautwurst, Raguse, & Meyerhof, 2002) sup-
presses NF-κB p65 nuclear translocation and intracellular cAMP in HGF-
1 cells, after treatment with LPS. In addition, down-regulation of gene
expression of many pro-inammatory cytokines occurred upon co-
incubation of cells with LPS and salicin, which resulted in a decreased
release of the pro-inammatory cytokine IL-8 (Zhou et al., 2021). In the
context of innate immunity, it has been shown that the activation of
TAS2R38 by corresponding bitter substances leads to calcium mobili-
zation, which might trigger the formation of NO as well-known anti-
bacterial agent (Bethineedi et al., 2023).
Inammatory processes in the stomach that are associated with the
release of various cytokines are often caused by an infection with the
bacterium Helicobacter pylori (H. pylori) (Bauditz et al., 1999; Beales &
Calam, 1997; Lv et al., 2019; Yamauchi et al., 2008). Worldwide, about
half of the population is infected with H. pylori (Suerbaum & Michetti,
2002). To protect itself from the human immune system, H. pylori has
developed specic adaptations in order to be able to settle in the gastric
mucosa. One of them is aimed at resisting the low pH in the stomach by
producing the enzyme urease. This enzyme catalyzes the breakdown of
urea into CO
2
and ammonia, neutralizing gastric acid (Salama, Hartung,
& Müller, 2013).
Among the pro-inammatory interleukins IL-17 is known to play a
crucial role in H. pylori infections. In infected mice IL-17 protein
expression was increased and associated with a strong neutrophil inl-
tration, which was signicantly reduced in IL-17 knock-out mice.
Moreover, the number of pathogens present in the stomach of the knock-
out mice was signicantly lower than in wild-type mice after 6 months
of infection (Shiomi et al., 2008). In humans, sustained secretion of IL-
17A, an important representative of the IL-17 family, by gastric cells
has been hypothesized to promote the development of gastric tumors
(Kang et al., 2023). Whether dietary peptides released during gastric
digestion may counteract a H. pylori-evoked release of pro-inammatory
cytokines and whether TAS2Rs are involved herein, has not been studied
so far.
We, therefore, hypothesized that gastric digestion of the sweet-
tasting protein thaumatin generates bitter peptides that reduce an
H. pylori-induced release of pro-inammatory interleukins with func-
tional involvement of TAS2Rs.
2. Material and methods
2.1. Chemicals
Thaumatin (mixture of the two forms thaumatin I and II, 99.4%
purity) was purchased from TCI Chemicals (Portland, USA), 1,5-car-
boxy-seminaphtorhodauor acetoxymethylester (SNARF-1-AM) and
Dulbecco's modied Eagle's medium GlutaMAX (DMEM) were pur-
chased from Thermo Fisher Scientic (USA). Fetal bovine serum (FBS
Supreme), trypsin/ethylenediaminetetraacetic acid, and pen-
icillin−streptomycin were obtained from PANBiotech GmbH (Aiden-
bach, Germany). Phosphate buffered saline was bought from Biozym
Scientic GmbH (Hessisch Oldendorf, Germany). Dimethyl sulfoxide
(DMSO) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) were purchased from Carl Roth (Karlsruhe, Germany).
All other compounds were ordered from Merck KGaA (Darmstadt, Ger-
many). Custom peptides (DAGGRQLNSGES, FNVPMDF, WTIN-
VEPGTKGGKIW, and AAASKGDAAL) were synthesized by Genscript
Biotech with a purity of >95% (New Jersey, USA). Double-distilled
water (ddH
2
O) from Elga Purelab Classic (Veolia Water Solutions &
Technologies, France) was used for all experiments. The composition of
Krebs-Ringer-HEPES buffer (KRHB), simulated salivary uid (SSF), and
simulated gastric uid (SGF) is based on previously published work
(Brodkorb et al., 2019; Richter et al., 2022).
2.2. In vitro digestion
For digestion of the intact plant protein thaumatin, 100 mg were
dissolved in SSF as described before (Brodkorb et al., 2019; Richter
et al., 2022) and incubated for 5 min at 37 ◦C and 5% CO
2
(standard
conditions) in four biological replicates. After the rst sampling, SGF
was added and the pH was adjusted to 3. Pepsin was added to initiate
simulated gastric digestion. The reaction was incubated under standard
conditions and samples were taken at 0.25, 0.5, 0.75, 1, 2, 3, 4, 5, and 6
h. The samples were stored at −80 ◦C until peptide identication by LC-
ToF-MS or quantitation by LC-MS/MS.
2.3. In vivo digestion
To carry out the in vivo digestion experiments, 1 g thaumatin was
dissolved in 5 mL of water and administered to pigs (German Landrace,
German Landrace ×minipig, age: about 20 weeks) in 6 biological rep-
licates. Two hours after thaumatin administration (Richter et al., 2022),
the animals were euthanized and the stomach contents were collected
and immediately frozen in liquid nitrogen. The following purication
and desalting was carried out as previously published (Richter et al.,
2022). The samples were stored at −80 ◦C until identication by LC-
ToF-MS or quantitation by LC-MS/MS.
2.4. Peptide identication by means of Ultra-High-Performance Liquid
Chromatography–Time-of-Flight Mass Spectrometry (UHPLC-ToF-MS)
Separations and measurements of peptides released from thaumatin
digestion were performed using a Sciex ExionLC AC (Sciex, Darmstadt,
Germany) coupled to a Sciex TripleTOF 6600 mass spectrometer (Sciex,
Darmstadt, Germany) adapted from the previously published protocol
(Richter et al., 2022). Data acquisition and instrumentation control were
performed with AnalystTF software (v 1.7.1; Sciex, Darmstadt, Ger-
many). The used gradient of 0.1% aqueous formic acid and acetonitrile
containing 0.1% formic acid was only slightly adjusted according to the
following scheme: 0 min, 5% B; 0.5 min, 5% B; 14 min, 60% B; 15 min,
98% B; 16 min, 98% B; 17 min, 5% B; and 20 min, 5% B. MaxQuant
software (Cox & Mann, 2008) was used for the identication of the
peptide sequences (version 1.6.3.4; unspecic digestion; variable mod-
ications: oxidation M, acetyl protein N-term, carbamidomethyl C,
phospho STY; peptide length between 4 and 25 amino acids; andromeda
score >10; max. Score: 202.27).
2.5. Quantitation of the thaumatin peptides via LC-MS/MS
Separations and measurements for peptide quantication were per-
formed using a Sciex ExionLC AC (Sciex, Darmstadt, Germany) coupled
to a 6500+QTrap LC-MS/MS system (Sciex, Darmstadt, Germany)
operating in the positive electrospray ionization mode. This was also
based on the previously published methodology (Richter et al., 2022).
While all other parameters were adopted, the gradient of 0.1% aqueous
formic acid and acetonitrile containing 0.1% formic acid was modied
as follows: 0 min, 10% B; 8 min, 40% B; 8.5 min, 98% B; 11 min, 98% B;
11.5 min, 10% B; and 15 min, 10% B. The optimal ionization parameters
(DP, CE, and CXP; see supplementary data Table S1) for each peptide
P. Richter et al.